Upadacitinib in Rheumatoid Arthritis: A Benefit–Risk Assessment Across a Phase III Program
Titel:
Upadacitinib in Rheumatoid Arthritis: A Benefit–Risk Assessment Across a Phase III Program
Auteur:
Conaghan, Philip G. Mysler, Eduardo Tanaka, Yoshiya Da Silva-Tillmann, Barbara Shaw, Tim Liu, John Ferguson, Ryan Enejosa, Jeffrey V. Cohen, Stanley Nash, Peter Rigby, William Burmester, Gerd